These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31909680)

  • 21. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
    Pogarell O; Gasser T; van Hilten JJ; Spieker S; Pollentier S; Meier D; Oertel WH
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):713-20. PubMed ID: 12023411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
    Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gabapentin on anxiety induced by simulated public speaking.
    de-Paris F; Sant'Anna MK; Vianna MR; Barichello T; Busnello JV; Kapczinski F; Quevedo J; Izquierdo I
    J Psychopharmacol; 2003 Jun; 17(2):184-8. PubMed ID: 12870565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial.
    Bawa Z; McCartney D; Bedoya-Pérez M; Lau NS; Fox R; MacDougall H; McGregor IS
    BMJ Open; 2024 Mar; 14(3):e082927. PubMed ID: 38531572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prior foot shock stress and Δ
    Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple simulated public speaking test for evaluating anxiolytic drugs.
    Guimarães FS; Kohem CL; Gus G; Fillmann HS; de-Vecino MC; de-Paoli CL; Ribeiro AM; Teixeira CC; Wannmacher L
    Braz J Med Biol Res; 1989; 22(9):1083-9. PubMed ID: 2699823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
    Zuardi AW; Shirakawa I; Finkelfarb E; Karniol IG
    Psychopharmacology (Berl); 1982; 76(3):245-50. PubMed ID: 6285406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Alternate Nostril Breathing Exercise on Experimentally Induced Anxiety in Healthy Volunteers Using the Simulated Public Speaking Model: A Randomized Controlled Pilot Study.
    Kamath A; Urval RP; Shenoy AK
    Biomed Res Int; 2017; 2017():2450670. PubMed ID: 29159176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration.
    Bonuccelli U; Ceravolo R; Salvetti S; D'Avino C; Del Dotto P; Rossi G; Murri L
    Neurology; 1997 Dec; 49(6):1587-90. PubMed ID: 9409351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
    Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
    Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
    Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabidiol in Anxiety and Sleep: A Large Case Series.
    Shannon S; Lewis N; Lee H; Hughes S
    Perm J; 2019; 23():18-041. PubMed ID: 30624194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of motor symptoms on self-reported anxiety in Parkinson's disease.
    Salazar RD; Le AM; Neargarder S; Cronin-Golomb A
    Parkinsonism Relat Disord; 2017 May; 38():26-30. PubMed ID: 28256435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cannabidiol (CBD) on regional cerebral blood flow.
    Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
    Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress.
    Granjeiro EM; Gomes FV; Guimarães FS; Corrêa FM; Resstel LB
    Pharmacol Biochem Behav; 2011 Oct; 99(4):743-8. PubMed ID: 21771609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group.
    Hundal H; Lister R; Evans N; Antley A; Englund A; Murray RM; Freeman D; Morrison PD
    J Psychopharmacol; 2018 Mar; 32(3):276-282. PubMed ID: 29086614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.
    McCartney D; Suraev AS; Doohan PT; Irwin C; Kevin RC; Grunstein RR; Hoyos CM; McGregor IS
    J Psychopharmacol; 2022 Dec; 36(12):1338-1349. PubMed ID: 35637624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.